[VIRTUAL] HERO Phase 3 Trial: Results Comparing Relugolix, an oral GnRH receptor antagonist, vs leuprolide acetate for advanced prostate cancer

[VIRTUAL] Pembrolizumab Plus Enzalutamide in Abiraterone-Pretreated Patients With Metastatic Castration-Resistant Prostate Cancer: Updated Results From KEYNOTE-365 Cohort C

[VIRTUAL] Impact of baseline disease volume and prior docetaxel therapy on prostate-specific antigen-related outcomes in patients with metastatic hormone-sensitive prostate cancer treated with enzalutamide plus androgen deprivation therapy

[VIRTUAL] Effect of cabazitaxel vs abiraterone or enzalutamide on patient-reported outcomes in metastatic castration-resistant prostate cancer: A pre-planned EQ-5D-5L analysis of the CARD study

[VIRTUAL] Apalutamide for Metastatic Castration-Sensitive Prostate Cancer in TITAN: Prognostic Importance of Prostate-Specific Antigen Responses

[VIRTUAL] Association of an immune-gene signature with pathologic response and outcome after neoadjuvant pembrolizumab (pembro), compared to neoadjuvant chemotherapy (NAC), in muscle-invasive bladder cancer (MIBC)

[VIRTUAL] Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial

[VIRTUAL] Can TURBT be avoided? Primary chemoablation with a reverse thermal gel containing mitomycin (UGN-102) in patients with low grade intermediate risk non-muscle invasive bladder cancer

[VIRTUAL] Methylation of SRD5A2 promoter predicts a better outcome for patients undergoing androgen deprivation therapy in patients with Castration-Resistant Prostate Cancer

[VIRTUAL] No-response at mpMRI after neoadjuvant pembrolizumab is a proxy of adverse pathological and oncological outcomes in patients treated with radical cystectomy: Interim results from the PURE01 study

[VIRTUAL] Adjuvant Intraarterial Chemotherapy Following Surgery in Treating Patients With Locally Advanced Bladder Cancer: a China,prospective, multicenter ,randomized phase III trial.

[VIRTUAL] Interim results of PEANUT: An open-label, single-arm, phase 2 study evaluating pembrolizumab plus nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as salvage therapy for metastatic urothelial carcinoma (UC)

[VIRTUAL] Interim analysis of phase 2 randomized prospective study on neoadjuvant apalutamide/abiraterone acetate with prednisone and the feasibility of performing nerve-sparing radical prostatectomy in men with high-risk prostate cancer (NCT02949284)

[VIRTUAL] The Association of Cancer Specific Anxiety with Disease Aggressiveness in Men on Active Surveillance of Prostate Cancer

[VIRTUAL] Decision regret, adverse outcomes and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial